7954259

Source:http://linkedlifedata.com/resource/pubmed/id/7954259

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0034656, umls-concept:C0040808, umls-concept:C0220901, umls-concept:C0729594, umls-concept:C1274040, umls-concept:C1446409, umls-concept:C1514559, umls-concept:C1522609, umls-concept:C1522673, umls-concept:C1554112
pubmed:issue	11
pubmed:dateCreated	1994-12-29
pubmed:abstractText	This study was designed to evaluate the prognostic importance of c-erbB2 overexpression in a standardized cohort of patients with axillary lymph node positive breast cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-15083, http://linkedlifedata.com/resource/pubmed/grant/CA-25224, http://linkedlifedata.com/resource/pubmed/grant/CA-37404
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0008-543X
pubmed:author	pubmed-author:GEHUJ MJM, pubmed-author:GrillJ PJP, pubmed-author:HartmannL CLC, pubmed-author:IngleJ NJN, pubmed-author:KrookJ EJE, pubmed-author:LIJ ZJZ, pubmed-author:MaihleN JNJ, pubmed-author:RocheP CPC, pubmed-author:WitzigT ETE, pubmed-author:WoldL ELE
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	74
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2956-63
pubmed:dateRevised	2010-3-24
pubmed:meshHeading	pubmed-meshheading:7954259-Breast Neoplasms, pubmed-meshheading:7954259-Chemotherapy, Adjuvant, pubmed-meshheading:7954259-Clinical Protocols, pubmed-meshheading:7954259-Cohort Studies, pubmed-meshheading:7954259-Disease-Free Survival, pubmed-meshheading:7954259-Female, pubmed-meshheading:7954259-Gene Expression Regulation, Neoplastic, pubmed-meshheading:7954259-Humans, pubmed-meshheading:7954259-Lymphatic Metastasis, pubmed-meshheading:7954259-Middle Aged, pubmed-meshheading:7954259-Multivariate Analysis, pubmed-meshheading:7954259-Postmenopause, pubmed-meshheading:7954259-Premenopause, pubmed-meshheading:7954259-Prognosis, pubmed-meshheading:7954259-Receptor, erbB-2, pubmed-meshheading:7954259-Receptors, Estrogen, pubmed-meshheading:7954259-Survival Rate, pubmed-meshheading:7954259-Treatment Outcome
pubmed:year	1994
pubmed:articleTitle	Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol.
pubmed:affiliation	Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't